The purpose of this paper was to assess the impact of warm and cold ischemia time on RNA and DNA integrity of lung cancer specimens, RNA expression levels, and patient-derived xenograft success rate.
The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.
Guerrera F, Tabbò F, Bessone L, Maletta F, Gaudiano M, Ercole E, Annaratone L, Todaro M, Boita M, Filosso PL, Solidoro P, Delsedime L, Oliaro A, Sapino A, Ruffini E, Inghirami G
Purpose
Conclusion
RIN of lung tumor specimens was affected by cold ischemia time but not warm ischemia time. Compared to controls with a cold ischemia time of 0-1 h, significantly lower RINs were observed among specimens with a cold ischemia time of 3-4 h [Odds Ratio (OR)=0.08, P=0.044], 4-9 h (OR=0.15, P=0.011), and ≥10 h (OR=0.25, P=0.022), as well as tumor specimens with a high pathological tumor-node-metastasis (TNM) stage (P<0.05). Absolute expression of common reference genes revealed a trend of higher mean Cq values (>25 cycles) among specimens with RINs <4 compared to specimens with a RIN between 4-10 (20-25 cycles). No clear pattern was observed between mean Cq values of individual reference genes and cold ischemia time. Low DNA quality (assessed by multiplex PCR) was observed among specimens with a low RIN value, although there was no clear influence of cold ischemia time.
The overall xenograft success rate was 33% (21 of the 63 primary tumors implanted). Based on multivariate adjusted models, low engraftment rate was correlated with cold ischemia times >10 h (P=0.047) and warm ischemia times >2 h (P=0.008). Engraftment success was positively associated with high tumor stage (OR=8.06, P=0.053) and squamous cell histology (OR=8.55, P= 0.01). Eight of the 21 tumors that were successfully engrafted had corresponding frozen tumor specimens that were then implanted in the mouse model, yielding an engraftment success rate of 50% and generating a PDX line comparable with corresponding fresh specimens.
Studies (2)
Purpose
The purpose of this study was to assess the impact of warm and cold ischemia time on RNA and DNA integrity of lung cancer specimens. Tumor and normal adjacent lung specimens collected by surgical resection from 135 patients, including those that had received chemotherapy and radiotherapy, were retrospectively examined. All lung specimens were immediately placed into a beta-ray sterilized plastic bag, vacuum-sealed, and transported at 4°C to the pathology laboratory for processing. Tumor and normal adjacent specimen were dissected and portions were embedded in OCT and then frozen; immersed in RNAlater, snap-frozen, and stored at -80°C; or placed in a freezing medium (containing RPMI, FBS, DMSO, and PEN-STREP) and stored in liquid nitrogen. Warm ischemia time, defined as the duration of surgery, ranged between 1 and 3 h. Cold ischemia time, defined as the time between specimen acquisition and cryopreservation, were ≤1 h, 1-2 h, 3-5 h, 6-9 h, or ≥10 h and occurred at 4°C. DNA was extracted using the phenol-chloroform method and RNA was extracted with Trizol and then treated with DNase. Total DNA and RNA was quantified by NanoDrop spectrophotometry. RNA integrity, reflected by RNA integrity number (RIN), was determined using a bioanalyzer. Absolute expression (Cq values) of the common reference genes glyceraldehyde 3-phosphate dehydrogenase (GAPDH), ACTIN, and human acidic ribosomal protein (HUPO) were determined by real-time qRT-PCR following reverse transcription with the Superscript First-Strand Synthesis System. DNA integrity was assessed by multiplex PCR of 100, 200, 300, and 400 and 600 bp fragments of TBXAS1, RAG1, PLZF, and AF4, respectively.
Summary of Findings
Of the 135 lung tumor specimens evaluated, 51% had a RIN≥7. RIN was affected by cold ischemia time but not warm ischemia time. A lower RIN was associated with a longer cold ischemia time, with significantly lower RINs observed after 3-4 h [Odds Ratio (OR)=0.08, P=0.044], 4-9 h (OR=0.15, P=0.011), and ≥10 h (OR=0.25, P=0.022), and a high pathological tumor-node-metastasis (TNM) stage (P<0.05). The percentage of specimens with a RIN ≥7 was not influenced by storage duration or tumor grade. Absolute expression of the common reference genes HUPO, ACTIN, and GAPDH in a 28 specimen subset revealed a trend of higher mean Cq values (>25 cycles) among specimens with RINs <4 compared to specimens with a RIN between 4-10 (20-25 cycles), but no clear pattern was observed between mean Cq values and cold ischemia time. When DNA quality was assessed by multiplex PCR of the same specimen subset, low DNA quality was observed among specimens with a low RIN value, although no clear differences were observed among specimens based on cold ischemia time.
Biospecimens
TissueLungPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNeoplasticNormal AdjacentPlatforms
DNAPCRRNAAutomated electrophoresis/BioanalyzerRNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Warm ischemia time 1-3 hBiospecimen Acquisition Cold ischemia time 1-2 h3-5 h6-9 h≤1 h≥10 hPCR Specific Length of gene fragment 100 bp200 bp300 bp400 bp600 bpPCR Specific Targeted nucleic acid AF4PLZFRAG1TBXAS1Real-time qRT-PCR Specific Targeted nucleic acid ACTINGAPDHHUPO
Purpose
The purpose of this study was to assess the impact of warm and cold ischemia time on RNA and DNA integrity of lung cancer specimens. Tumor and normal adjacent lung specimens collected by surgical resection from 135 patients, including those that had received chemotherapy and radiotherapy, were retrospectively examined. All lung specimens were immediately placed into a beta-ray sterilized plastic bag, vacuum-sealed, and transported at 4°C to the pathology laboratory for processing. Tumor and normal adjacent specimen were dissected and portions were embedded in OCT and then frozen; immersed in RNAlater, snap-frozen, and stored at -80°C; or placed in a freezing medium (containing RPMI, FBS, DMSO, and PEN-STREP) and stored in liquid nitrogen. Warm ischemia time, defined as the duration of surgery, ranged between 1 and 3 h. Cold ischemia time, defined as the time between specimen acquisition and cryopreservation, were ≤1 h, 1-2 h, 3-5 h, 6-9 h, or ≥10 h and occurred at 4°C. DNA was extracted using the phenol-chloroform method and RNA was extracted with Trizol and then treated with DNase. Total DNA and RNA was quantified by NanoDrop spectrophotometry. RNA integrity, reflected by RNA integrity number (RIN), was determined using a bioanalyzer. Absolute expression (Cq values) of the common reference genes GAPDH, ACTIN, and HUPO were determined by real-time qRT-PCR following reverse transcription with the Superscript First-Strand Synthesis System. DNA integrity was assessed by multiplex PCR of 100, 200, 300, and 400 and 600 bp fragments of TBXAS1, RAG1, PLZF, and AF4, respectively.
Summary of Findings
Of the 135 lung tumor specimens evaluated, 51% had a RIN≥7. RIN was affected by cold ischemia time but not warm ischemia time. A lower RIN was associated with a longer cold ischemia time, with significantly lower RINs observed after 3-4 h [Odds Ratio (OR)=0.08, P=0.044], 4-9 h (OR=0.15, P=0.011), and ≥10 h (OR=0.25, P=0.022), and a high pathological tumor-node-metastasis (TNM) stage (P<0.05). The percentage of specimens with a RIN ≥7 was not influenced by storage duration or tumor grade. Absolute expression of the common reference genes HUPO, ACTIN, and GAPDH in a 28 specimen subset revealed a trend of higher mean Cq values (>25 cycles) among specimens with RINs <4 compared to specimens with a RIN between 4-10 (20-25 cycles), but no clear pattern was observed between mean Cq values and cold ischemia time. When DNA quality was assessed by multiplex PCR of the same specimen subset, low DNA quality was observed among specimens with a low RIN value, although no clear differences were observed among specimens based on cold ischemia time.
Biospecimens
Patient Derived ModelLungPreservation Types
None (Fresh)FrozenDiagnoses
NeoplasticCarcinomaPlatforms
MorphologyH-and-E microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Warm ischemia time 1-3 hBiospecimen Acquisition Cold ischemia time 1-2 h3-5 h6-9 h≤1 h≥10 hBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)